Literature DB >> 8881209

[Local therapy of rectum carcinoma. A prospective follow-up study].

B Mentges1, G Buess, G Effinger, K Manncke, H D Becker.   

Abstract

Local therapy of rectal carcinoma with the method of TEM was performed in 98 patients during the period from August 1, 1989 to January 31, 1994. 56 of the patients had pT1, 27 pT2, and 15 pT3 tumours. There was no lethality. The rate of complications, which required operative intervention, was 8%. No lymph node metastases were found in the specimens of the patients with pT1 tumours, who were re-resected, because the margin of the primary specimen were judged to be not free of tumour. In the specimens of the re-resected patients with pT2 carcinomas, lymph node involvement was more common than remnants of the primary tumour. Two of the patients with local therapy of pT1 low-risk carcinomas developed a recurrence so far. A secondary procedure for cure according to oncologic criteria could be performed in both cases. In selected cases the local therapy of rectal carcinoma avoids the high morbidity and mortality of the classical operation. Live quality will be improved, especially if an artificial anus can be avoided. In case of a recurrence the chance of a secondary procedure for cure is not to be underestimated.

Entities:  

Mesh:

Year:  1996        PMID: 8881209

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  2 in total

1.  UltraCision or high-frequency knife in transanal endoscopic microsurgery (TEM)? Advantages of a new procedure.

Authors:  C Langer; P Markus; T Liersch; L Füzesi; H Becker
Journal:  Surg Endosc       Date:  2001-03-13       Impact factor: 4.584

2.  Postoperative complications in the treatment of rectal neoplasia by transanal endoscopic microsurgery: a prospective study of risk factors and time course.

Authors:  Carlos Frederico S Marques; Caio Sergio R Nahas; Ulysses Ribeiro; Leonardo A Bustamante; Rodrigo Ambar Pinto; Eduardo Kenzo Mory; Ivan Cecconello; Sergio Carlos Nahas
Journal:  Int J Colorectal Dis       Date:  2016-02-09       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.